Conversely, knockdown of TBX21, ARHGAP29, or MYCT1, or LiCl application, which enhances GSK3β phosphorylation, counteracted TBX21-mediated inhibition of CRC cell migration in vitro and in vivo. The gene discussed is GSK3B; the disease is colorectal carcinoma.